Mark Kruzel

438 total citations
9 papers, 278 citations indexed

About

Mark Kruzel is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Mark Kruzel has authored 9 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Clinical Biochemistry and 2 papers in Molecular Biology. Recurrent topics in Mark Kruzel's work include Bacterial Identification and Susceptibility Testing (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Streptococcal Infections and Treatments (2 papers). Mark Kruzel is often cited by papers focused on Bacterial Identification and Susceptibility Testing (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Streptococcal Infections and Treatments (2 papers). Mark Kruzel collaborates with scholars based in United States, China and France. Mark Kruzel's co-authors include Jeffrey K. Actor, Kerry J. Welsh, Cole T. Lewis, Lisa Y. Armitige, Audrey Wanger, John Mohr, Sunhee Hwang, Amitava Dasgupta, Shen‐An Hwang and April N. Abbott and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Clinical Microbiology and Biochimie.

In The Last Decade

Mark Kruzel

9 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kruzel United States 8 119 76 70 64 39 9 278
Padmanaban Venkatesan India 7 43 0.4× 33 0.4× 72 1.0× 12 0.2× 27 0.7× 17 314
Mitsuo Kitahara United States 11 138 1.2× 21 0.3× 40 0.6× 36 0.6× 24 0.6× 19 350
Michaelle B. Jones United States 10 114 1.0× 76 1.0× 50 0.7× 28 0.4× 99 2.5× 12 326
Lucia Mališová Czechia 11 53 0.4× 14 0.2× 77 1.1× 33 0.5× 20 0.5× 27 294
Raquel M. Marques Portugal 12 90 0.8× 134 1.8× 72 1.0× 8 0.1× 14 0.4× 14 387
Dagmara I. Moscoso United States 6 93 0.8× 42 0.6× 119 1.7× 19 0.3× 20 0.5× 9 268
Sumanee Nilgate Thailand 7 88 0.7× 25 0.3× 147 2.1× 14 0.2× 18 0.5× 13 290
Fusae Takamine Japan 9 144 1.2× 61 0.8× 347 5.0× 29 0.5× 10 0.3× 14 514
Kjell Svéen Norway 10 39 0.3× 24 0.3× 132 1.9× 43 0.7× 56 1.4× 31 430
Joy Logan United States 10 129 1.1× 29 0.4× 27 0.4× 10 0.2× 44 1.1× 18 338

Countries citing papers authored by Mark Kruzel

Since Specialization
Citations

This map shows the geographic impact of Mark Kruzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kruzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kruzel more than expected).

Fields of papers citing papers by Mark Kruzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kruzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kruzel. The network helps show where Mark Kruzel may publish in the future.

Co-authorship network of co-authors of Mark Kruzel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kruzel. A scholar is included among the top collaborators of Mark Kruzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kruzel. Mark Kruzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Leader, Benjamin, et al.. (2022). Molecular reflex testing in non-small cell lung cancer: An optimal approach?. Journal of Clinical Oncology. 40(16_suppl). 3127–3127. 1 indexed citations
2.
Kruzel, Marian L., Jeffrey K. Actor, Michał Zimecki, et al.. (2013). Novel recombinant human lactoferrin: Differential activation of oxidative stress related gene expression. Journal of Biotechnology. 168(4). 666–675. 63 indexed citations
3.
Kruzel, Mark, Cole T. Lewis, Kerry J. Welsh, et al.. (2011). Determination of Vancomycin and Daptomycin MICs by Different Testing Methods for Methicillin-Resistant Staphylococcus aureus. Journal of Clinical Microbiology. 49(6). 2272–2273. 38 indexed citations
4.
Welsh, Kerry J., Kimberly A. Skrobarcek, April N. Abbott, et al.. (2011). Predictors of Relapse of Methicillin-Resistant Staphylococcus aureus Bacteremia after Treatment with Vancomycin. Journal of Clinical Microbiology. 49(10). 3669–3672. 30 indexed citations
5.
Welsh, Kerry J., April N. Abbott, Mark Kruzel, et al.. (2010). Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-Resistant Staphylococcus aureus Bacteremia in Pediatric Patients Treated with Vancomycin. Journal of Clinical Microbiology. 48(3). 894–899. 34 indexed citations
6.
Hwang, Shen‐An, et al.. (2008). Immune Modulation of Macrophage Pro-Inflammatory Response by Goldenseal and Astragalus Extracts. Journal of Medicinal Food. 11(3). 493–498. 40 indexed citations
7.
Hwang, Sunhee, Mark Kruzel, & Jeffrey K. Actor. (2008). Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages. Biochimie. 91(1). 76–85. 30 indexed citations
8.
Volcik, Kelly A., Susan H. Blanton, Mark Kruzel, et al.. (2002). Testing for genetic associations with the PAX gene family in a spina bifida population. American Journal of Medical Genetics. 110(3). 195–202. 18 indexed citations
9.
Volcik, Kelly A., Susan H. Blanton, Mark Kruzel, et al.. (2002). Testing for genetic associations in a spina bifida population: Analysis of the HOX gene family and human candidate gene regions implicated by mouse models of neural tube defects. American Journal of Medical Genetics. 110(3). 203–207. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026